Market News

2U (TWOU) Gets Macquarie Civerage with $71.0 Target; Becker Capital Management Raised Its Gilead Sciences (GILD) Holding

Among 12 analysts covering 2U (NASDAQ:TWOU), 12 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. 2U has $80.0 highest and $31 lowest target. $62.27’s average target is 6.63% above currents $58.4 stock price. 2U had 34 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of 2U, Inc. (NASDAQ:TWOU) has “Outperform” rating given on Wednesday, November 8 by BMO Capital Markets. On Friday, July 15 the stock rating was initiated by Needham with “Buy”. The company was maintained on Tuesday, August 8 by Credit Suisse. KeyBanc Capital Markets maintained the shares of TWOU in report on Monday, November 20 with “Overweight” rating. Oppenheimer maintained 2U, Inc. (NASDAQ:TWOU) rating on Wednesday, November 8. Oppenheimer has “Outperform” rating and $70 target. Robert W. Baird maintained the shares of TWOU in report on Friday, October 6 with “Buy” rating. The firm has “Buy” rating by Compass Point given on Friday, February 26. Needham maintained the shares of TWOU in report on Wednesday, November 8 with “Buy” rating. The firm has “Buy” rating by Needham given on Friday, August 7. Robert W. Baird maintained the shares of TWOU in report on Wednesday, September 20 with “Buy” rating.

Becker Capital Management Inc increased Gilead Sciences Inc (GILD) stake by 25.91% reported in 2017Q2 SEC filing. Becker Capital Management Inc acquired 141,560 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Becker Capital Management Inc holds 687,979 shares with $48.70M value, up from 546,419 last quarter. Gilead Sciences Inc now has $95.74 billion valuation. It closed at $73.29 lastly. It is down 21.80% since December 7, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

2U, Inc. provides cloud-based software-as-a-service solutions for nonprofit colleges and universities to deliver education to students. The company has market cap of $3.05 billion. The Company’s cloud SaaS platform solutions include online campus, an online learning platform that enables its clients to offer educational content together with instructor-led classes in a live, intimate, and engaging setting through proprietary Web and mobile applications. It currently has negative earnings. The companyÂ’s integrated back-end applications launch, operate, and support clients' programs, as well as provide clients with real-time data and analytical insight related to student performance and engagement, student satisfaction, and enrollment.

The stock decreased 0.60% or $0.35 during the last trading session, reaching $58.4. About 715,743 shares traded or 56.21% up from the average. 2U, Inc. (NASDAQ:TWOU) has risen 55.92% since December 7, 2016 and is uptrending. It has outperformed by 39.22% the S&P500.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 19 have Buy rating, 0 Sell and 11 Hold. Therefore 63% are positive. Gilead Sciences had 107 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Hold” rating by Jefferies given on Tuesday, March 15. The firm has “Equal-Weight” rating given on Thursday, May 26 by Morgan Stanley. The stock has “Hold” rating by Jefferies on Tuesday, July 11. The company was maintained on Tuesday, July 25 by Mizuho. Needham maintained the stock with “Hold” rating in Tuesday, October 3 report. The stock has “Strong Buy” rating by Jyske Bank on Thursday, September 10. The firm earned “Hold” rating on Friday, July 29 by Argus Research. The stock has “Buy” rating by Citigroup on Thursday, February 25. The firm earned “Outperform” rating on Tuesday, October 20 by Oppenheimer. The firm has “Outperform” rating given on Wednesday, November 2 by BMO Capital Markets.

Investors sentiment increased to 0.93 in 2017 Q2. Its up 0.02, from 0.91 in 2017Q1. It improved, as 78 investors sold GILD shares while 538 reduced holdings. 110 funds opened positions while 462 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. Btg Pactual Asset Mngmt stated it has 13,127 shares. S&Co Incorporated has 0.06% invested in Gilead Sciences, Inc. (NASDAQ:GILD). 494 were accumulated by Motco. San Francisco Sentry Grp Incorporated (Ca) holds 0.18% in Gilead Sciences, Inc. (NASDAQ:GILD) or 7,094 shares. Etrade Cap Ltd Liability owns 34,362 shares. Rdl Fincl has 4.79% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Tower Bridge Advsr accumulated 0% or 3,779 shares. Curbstone Financial Mgmt reported 13,970 shares. Moreover, Buckingham Cap Mngmt has 0.31% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Cap Advsrs Ok has 0.86% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 194,665 shares. The Virginia-based Vnbtrust National Association has invested 0.09% in Gilead Sciences, Inc. (NASDAQ:GILD). Sii Invs Wi holds 34,727 shares. Caisse De Depot Et Placement Du Quebec has invested 0.37% in Gilead Sciences, Inc. (NASDAQ:GILD). Hourglass Cap Limited Liability holds 2.05% or 115,647 shares in its portfolio. Somerville Kurt F accumulated 35,252 shares or 0.51% of the stock.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *